PRF Technologies (PRFX) Intangibles (2025)
PRF Technologies (PRFX) recorded quarterly Intangibles of $7.4 million in Q4 2025, up 4.02% on a QoQ basis from $7.1 million in Q2 2025.
PRF Technologies (PRFX) Intangibles (2025) Analysis & Trends
PRF Technologies has disclosed Intangibles across 1 years of filings, most recently posting $7.4 million for Q4 2025.
- Quarterly Intangibles changed N/A year-over-year to $7.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.4 million (changed N/A YoY) and the FY2025 annual result came in at $7.4 million, changed N/A from the prior year.
- Intangibles advanced to $7.4 million in Q4 2025, from $7.1 million in the prior quarter.
- Over five years, Intangibles peaked at $7.4 million in Q4 2025 and troughed at $7.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.61 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 959.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.57 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.23 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.80 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 261.03 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 936.46 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | 7.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.41 Mn |
| Jun 30, 2025 | 7.12 Mn |